Cleared Traditional

K952331 - AOI LC-40 PHACOEMULSIFIER

K952331 is an FDA 510(k) clearance for AOI LC-40 PHACOEMULSIFIER, manufactured by American Optisurgical, Inc.. The device is a Class 2 Ophthalmic device with product code HQC cleared through the Traditional 510(k) pathway after a 90-day FDA review.

K952331 · American Optisurgical, Inc. · Ophthalmic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 1995
Decision
90d
Days
Class 2
Risk

K952331 is an FDA 510(k) clearance for the AOI LC-40 PHACOEMULSIFIER. Classified as Unit, Phacofragmentation (product code HQC), Class II - Special Controls.

Submitted by American Optisurgical, Inc. (Irvine, US). The FDA issued a Cleared decision on August 16, 1995 after a review of 90 days - within the typical 510(k) review window.

This device falls under the Ophthalmic FDA review panel, regulated under 21 CFR 886.4670 - the FDA ophthalmic device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Ophthalmic review framework, consistent with the majority of Class II 510(k) submissions.

View all American Optisurgical, Inc. devices

FDA 510(k) Submission Details - K952331

510(k) Number K952331 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 18, 1995
Decision Date August 16, 1995
Days to Decision 90 days
Submission Type Traditional
Review Panel Ophthalmic (OP)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
20d faster than avg
Panel avg: 110d · This submission: 90d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

HQC Device Classification - Class 2, Special Controls

Product Code HQC Unit, Phacofragmentation
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 886.4670
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Ophthalmic devices follow this clearance model.

Regulatory Peers - HQC Unit, Phacofragmentation

All 163
Devices cleared under the same product code (HQC) and FDA review panel - the closest regulatory comparables to K952331.
IOLAB.SITE CD PHACOEMULSIFICATION MODULE
K944993 · Chiron Vision Corp. · Oct 1995
IOLAB/SITE PERISTALTIC MODULE
K944995 · Chiron Vision Corp. · Oct 1995
PHACO TIP
K950881 · American Optical Corp. · Sep 1995
ALCON SERIES 20000 LEGACY PHACOEMULSIFIER
K952213 · Alcon Laboratories · Aug 1995
STORZ DP4101 BASIC I/A PACK
K953078 · Storz Instrument Co. · Aug 1995
STORZ MICROSEAL PHACOEMULSIFICATION NEEDLES (IMPORTATION)
K951824 · Nidek, Inc. · Jul 1995